229 related articles for article (PubMed ID: 28874746)
1. RGMa inhibition with human monoclonal antibodies promotes regeneration, plasticity and repair, and attenuates neuropathic pain after spinal cord injury.
Mothe AJ; Tassew NG; Shabanzadeh AP; Penheiro R; Vigouroux RJ; Huang L; Grinnell C; Cui YF; Fung E; Monnier PP; Mueller BK; Tator CH
Sci Rep; 2017 Sep; 7(1):10529. PubMed ID: 28874746
[TBL] [Abstract][Full Text] [Related]
2. Delayed administration of the human anti-RGMa monoclonal antibody elezanumab promotes functional recovery including spontaneous voiding after spinal cord injury in rats.
Mothe AJ; Coelho M; Huang L; Monnier PP; Cui YF; Mueller BK; Jacobson PB; Tator CH
Neurobiol Dis; 2020 Sep; 143():104995. PubMed ID: 32590037
[TBL] [Abstract][Full Text] [Related]
3. Delayed administration of elezanumab, a human anti-RGMa neutralizing monoclonal antibody, promotes recovery following cervical spinal cord injury.
Mothe AJ; Jacobson PB; Caprelli M; Ulndreaj A; Rahemipour R; Huang L; Monnier PP; Fehlings MG; Tator CH
Neurobiol Dis; 2022 Oct; 172():105812. PubMed ID: 35810963
[TBL] [Abstract][Full Text] [Related]
4. Elezanumab, a human anti-RGMa monoclonal antibody, promotes neuroprotection, neuroplasticity, and neurorecovery following a thoracic hemicompression spinal cord injury in non-human primates.
Jacobson PB; Goody R; Lawrence M; Mueller BK; Zhang X; Hooker BA; Pfleeger K; Ziemann A; Locke C; Barraud Q; Droescher M; Bernhard J; Popp A; Boeser P; Huang L; Mollon J; Mordashova Y; Cui YF; Savaryn JP; Grinnell C; Dreher I; Gold M; Courtine G; Mothe A; Tator CH; Guest JD
Neurobiol Dis; 2021 Jul; 155():105385. PubMed ID: 33991647
[TBL] [Abstract][Full Text] [Related]
5. Synapse formation of the cortico-spinal axons is enhanced by RGMa inhibition after spinal cord injury.
Kyoto A; Hata K; Yamashita T
Brain Res; 2007 Dec; 1186():74-86. PubMed ID: 17996222
[TBL] [Abstract][Full Text] [Related]
6. Anti-repulsive guidance molecule-a antibody treatment and repetitive transcranial magnetic stimulation have synergistic effects on motor recovery after spinal cord injury.
Nakanishi T; Fujita Y; Tanaka T; Yamashita T
Neurosci Lett; 2019 Sep; 709():134329. PubMed ID: 31200090
[TBL] [Abstract][Full Text] [Related]
7. RGMa inhibition promotes axonal growth and recovery after spinal cord injury.
Hata K; Fujitani M; Yasuda Y; Doya H; Saito T; Yamagishi S; Mueller BK; Yamashita T
J Cell Biol; 2006 Apr; 173(1):47-58. PubMed ID: 16585268
[TBL] [Abstract][Full Text] [Related]
8. Targeting repulsive guidance molecule A to promote regeneration and neuroprotection in multiple sclerosis.
Demicheva E; Cui YF; Bardwell P; Barghorn S; Kron M; Meyer AH; Schmidt M; Gerlach B; Leddy M; Barlow E; O'Connor E; Choi CH; Huang L; Veldman GM; Rus H; Shabanzadeh AP; Tassew NG; Monnier PP; Müller T; Calabresi PA; Schoemaker H; Mueller BK
Cell Rep; 2015 Mar; 10(11):1887-98. PubMed ID: 25801027
[TBL] [Abstract][Full Text] [Related]
9. Modifying lipid rafts promotes regeneration and functional recovery.
Tassew NG; Mothe AJ; Shabanzadeh AP; Banerjee P; Koeberle PD; Bremner R; Tator CH; Monnier PP
Cell Rep; 2014 Aug; 8(4):1146-59. PubMed ID: 25127134
[TBL] [Abstract][Full Text] [Related]
10. The repulsive guidance molecule, RGMa, promotes retinal ganglion cell survival in vitro and in vivo.
Koeberle PD; Tura A; Tassew NG; Schlichter LC; Monnier PP
Neuroscience; 2010 Aug; 169(1):495-504. PubMed ID: 20457227
[TBL] [Abstract][Full Text] [Related]
11. Activated microglia inhibit axonal growth through RGMa.
Kitayama M; Ueno M; Itakura T; Yamashita T
PLoS One; 2011; 6(9):e25234. PubMed ID: 21957482
[TBL] [Abstract][Full Text] [Related]
12. Treatment With the Neutralizing Antibody Against Repulsive Guidance Molecule-a Promotes Recovery From Impaired Manual Dexterity in a Primate Model of Spinal Cord Injury.
Nakagawa H; Ninomiya T; Yamashita T; Takada M
Cereb Cortex; 2019 Feb; 29(2):561-572. PubMed ID: 29315368
[TBL] [Abstract][Full Text] [Related]
13. Anti-CD11d integrin antibody treatment restores normal serotonergic projections to the dorsal, intermediate, and ventral horns of the injured spinal cord.
Oatway MA; Chen Y; Bruce JC; Dekaban GA; Weaver LC
J Neurosci; 2005 Jan; 25(3):637-47. PubMed ID: 15659600
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of neogenin promotes neuronal survival and improved behavior recovery after spinal cord injury.
Chen J; Shifman MI
Neuroscience; 2019 Jun; 408():430-447. PubMed ID: 30943435
[TBL] [Abstract][Full Text] [Related]
15. RGMa Signal in Macrophages Induces Neutrophil-Related Astrocytopathy in NMO.
Iwamoto S; Itokazu T; Sasaki A; Kataoka H; Tanaka S; Hirata T; Miwa K; Suenaga T; Takai Y; Misu T; Fujihara K; Yamashita T
Ann Neurol; 2022 Apr; 91(4):532-547. PubMed ID: 35167145
[TBL] [Abstract][Full Text] [Related]
16. Promoting functions of microRNA-29a/199B in neurological recovery in rats with spinal cord injury through inhibition of the RGMA/STAT3 axis.
Yang W; Sun P
J Orthop Surg Res; 2020 Sep; 15(1):427. PubMed ID: 32948213
[TBL] [Abstract][Full Text] [Related]
17. Elezanumab, a clinical stage human monoclonal antibody that selectively targets repulsive guidance molecule A to promote neuroregeneration and neuroprotection in neuronal injury and demyelination models.
Huang L; Fung E; Bose S; Popp A; Böser P; Memmott J; Kutskova YA; Miller R; Tarcsa E; Klein C; Veldman GM; Mueller BK; Cui YF
Neurobiol Dis; 2021 Nov; 159():105492. PubMed ID: 34478849
[TBL] [Abstract][Full Text] [Related]
18. A modified collagen scaffold facilitates endogenous neurogenesis for acute spinal cord injury repair.
Fan C; Li X; Xiao Z; Zhao Y; Liang H; Wang B; Han S; Li X; Xu B; Wang N; Liu S; Xue W; Dai J
Acta Biomater; 2017 Mar; 51():304-316. PubMed ID: 28069497
[TBL] [Abstract][Full Text] [Related]
19. Repulsive guidance molecule b inhibits neurite growth and is increased after spinal cord injury.
Liu X; Hashimoto M; Horii H; Yamaguchi A; Naito K; Yamashita T
Biochem Biophys Res Commun; 2009 May; 382(4):795-800. PubMed ID: 19324014
[TBL] [Abstract][Full Text] [Related]
20. The expression of repulsive guidance molecule a after traumatic brain injury: Time-course changes in gene expression in a murine model of controlled cortical impact.
Uemura E; Tajima G; Murahashi S; Matsumoto N; Tokunaga A; Miura M; Murase T; Ikematsu K; Tasaki O
J Trauma Acute Care Surg; 2021 Feb; 90(2):281-286. PubMed ID: 33264266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
